Gland Pharma consolidated net profit rises 96.57% in the March 2026 quarter

Sales rise 22.31% to Rs 1742.79 crore

Net profit of Gland Pharma rose 96.57% to Rs 366.68 crore in the quarter ended March 2026 as against Rs 186.54 crore during the previous quarter ended March 2025. Sales rose 22.31% to Rs 1742.79 crore in the quarter ended March 2026 as against Rs 1424.91 crore during the previous quarter ended March 2025.

For the full year,net profit rose 47.07% to Rs 1027.32 crore in the year ended March 2026 as against Rs 698.53 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 6430.65 crore in the year ended March 2026 as against Rs 5616.50 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	1742.79	1424.91	22	6430.65	5616.50	15
OPM %	29.44	24.39	-	25.34	22.59	-
PBDT	614.46	384.09	60	1912.60	1440.53	33
PBT	505.80	288.33	75	1488.93	1062.66	40
NP	366.68	186.54	97	1027.32	698.53	47

Powered by Capital Market - Live News